Work-related asthma: Diagnosis and prognosis of immunological occupational asthma and work-exacerbated asthma

Journal of Investigational Allergology and Clinical Immunology

Volumn 24, Issue 6, 2014, Pages 396-405

  Muñoz, Xavier ^a,b,c   Cruz, M J ^a,b   Bustamante, V ^d   Lopez Campos, J L ^b,e   Barreiro, E ^b,f  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL DE BASURTO   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Irritants; Peak expiratory flow; Specific inhalation challenge; Workplace

Indexed keywords

COCHINEAL CARMINE; FOOD DYE; IMMUNOGLOBULIN E; ISOCYANATE; METHACHOLINE; UNCLASSIFIED DRUG;

DISEASE EXACERBATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; EXHALED BREATH CONDENSATE; FORCED EXPIRATORY VOLUME; FRACTIONAL EXHALED NITRIC OXIDE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FUNCTION; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; PEAK EXPIRATORY FLOW; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREVALENCE; PRICK TEST; PROGNOSIS; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT PARAMETERS; REVIEW; SENSITIVITY AND SPECIFICITY; SENSITIZATION; SPIROMETRY; WESTERN BLOTTING; WORK ENVIRONMENT; WORK EXACERBATED ASTHMA; ASTHMA, OCCUPATIONAL; LUNG FUNCTION TEST; MEDICAL RECORD; PATHOPHYSIOLOGY; WORKPLACE;

ASTHMA, OCCUPATIONAL; HUMANS; MEDICAL RECORDS; OCCUPATIONAL EXPOSURE; PROGNOSIS; RESPIRATORY FUNCTION TESTS; WORKPLACE;

EID: 84918825890     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. Kazani S, Israel E. Update in asthma 2011. Am J Respir Crit Care Med. 2012; 186: 35-40.
2. Quirce S. Asthma in Alergologica-2005. J Invest Allergol Clin Immunol. 2009; 19(Suppl. 2): 14-20.
3. Pelta Fernandez R, De Miguel Diez J, Alvarez Perea A, Magan Tapia P, Jimenez Garcia R, Sanz De Burgoa Gomez-Pinan V. Factores de riesgo de asma de inicio entre los 12 y 40 anos. Resultados del estudio FENASMA. Arch Bronconeumol. 2011; 47: 433-40.
4. Rabec C, De Lucas Ramos P, Veale D. Complicaciones respiratorias de la obesidad. Arch Bronconeumol. 2011: 47: 252-61.
5. Kunzli N, Bridevaux PO, Liu LJ, Garcia-Esteban R, Schindler C, Gerbase MW, Sunyer J, Keidel D, Rochat T; Swiss Cohort Study on Air Pollution and Lung Diseases in Adults. Traffic-related air pollution correlates with adult-onset asthma among neversmokers. Thorax. 2009; 64: 664-70.
6. Poon AH, Laprise C, Lemire M, Montpetit A, Sinnett D, Schurr E, Hudson TJ. Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. Am J Respir Crit Care Med. 2004; 170: 967-73.
7. Douwes J, Brooks C, Pearce N. Asthma nervosa: old concept, new insights. Eur Respir J. 2011; 37: 986-90.
8. Atwood CS, Bowen RL. A multi-hit endocrine model of intrinsic adult-onset asthma. Ageing Res Rev. 2008; 7: 114-25.
9. Farquhar H, Stewart A, Mitchell E, Crane J, Eyers S, Weatherall M, Beasley R. The role of paracetamol in the pathogenesis of asthma. Clin Exp Allergy. 2010; 40: 32-41.
10. Polosa R, Russo C, Caponnetto P, Bertino G, Sarva M, Antic T, Mancuso S, Al-Delaimy WK. Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study. Respir Res. 2011; 12: 16.
11. Tarlo SM. Occupational exposures and adult asthma. Immunol Allergy Clin North Am. 2008; 28: 563-76.
12. Ghosh RE, Cullinan P, Fishwick D, Hyle J, Warburton CJ, Strachan DP, Butland BK, Jarvis D. Asthma and occupation in the 1958 birth cohort. Thorax. 2013; 68: 365-71.
13. Balmes J, Becklake M, Blanch P, Henneberger P, Kreiss K, Mapp C, Milton D, Schwartz D, Toren K, Viegi G; Environmental and Occupational Health Assembly, American Thoracic Society. American Thoracic Society Statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med. 2003; 167: 787-97.
14. Kogevinas M, Zock JP, Jarvis D, Kromhout H, Lillienberg L, Plana E, Radon K, Toren K, Alliksoo A, Benke G, Blanc PD, Dahlman-Hoglund A, D'Errico A, Hery M, Kennedy S, Kunzli N, Leynaert B, Mirabelli MC, Muniozguren N, Norback D, Olivieri M, Payo F, Villani S, van Sprundel M, Urrutia I, Wieslander G, Sunyer J, Anto JM. Exposure to substances in the workplace and newonset asthma: an international prospective population-based study (ECRHS-II). Lancet. 2007; 370: 336-41.
15. Uriarte SA, Fernandez-Nieto M, Sastre J. Occupational Asthma Due to Polyvinyl Chloride and Methyl Methacrylate in a Plumber J Invest Allergol Clin Immunol. 2013; 23(6): 435-47.
16. Rodriguez del Rio P, Tudela Garcia JI, Narganes NJ, Fernandez-Caldas E, Rodriguez-Garcia V, Subiza J. Occupational asthma caused by the inhalation of Tyrophagus putrescentiae allergens in a dry-cured ham transporter allergic to shrimp. J Invest Allergol Clin Immunol. 2012; 22(5): 372-92.
17. Enriquez A, Fernandez C, Jimenez A, Seoane E, Alcorta AR, Rodriguez J. Occupational Asthma Induced by Mucor Species Contaminating Esparto Fibers. J Invest Allergol Clin Immunol 2011; 21(3): 248-52.
18. Bernstein IL, Bernstein DI, Chan-Yeung M, Malo JL. Definitions and classification of asthma in the workplace. In: Malo JL, Chan-Yeung M and Bernstein DI, editors. Asthma in the workplace. Fourth Edition. Boca Raton; CRC Press; 2013, p. 1-5.
19. Tarlo SM, Balmes J, Balkisson R, Beach J, Beckett W, Bernstein D, Blanc PD, Brooks SM, Cowl CT, Daroowalla F, Harber P, Lemiere C, Liss GM, Pacheco KA, Redlich CA, Rowe B, Heitzer J. ACCP consensus statement; diagnosis and management of work-related asthma. Chest. 2008; 134: 1S-41S.
20. Baur X, Aassen TB, Burge PS, Heederik D, Henneberger PK, Maestrelli P, Schlunssen V, Vandenplas O, Wilken D; ERS Task Force on the Management of Work-related Asthma. The management of work-related asthma guidelines: a broader perspective. Eur Respir Rev. 2012; 21: 125-39.
21. Henneberger PK, Redich CA, Callahan DB, Harber P, Lemiere C, Martin J, Tarlo SM, Vandenplas O, Toren K; ATS Ad Hoc Committee on Work-Exacerbated Asthma. An official American Thoracic Society Statement: work-exacerbated asthma. Am J Respir Crit Care Med. 2011; 184: 368-78.
22. Garcia Gomez M, Urbanos Garrido R, Castaneda Lopez R, Lopez Menduina P. Costes sanitarios directos del asma de origen laboral en Espana: una estimacion para el ano 2008: Arch Bronconeumol. 2012; 48(10): 355-61.
23. Ruiz Manzano J, Alfageme Michavila I, Chiner Vives E, Martinez Gonzalez C. Valoracion de la discapacidad en los enfermos respiratorios. Arch Bronconeumol. 2012; 48(8): 290-5.
24. Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest. 1985; 88: 376-84.
25. Brooks SM, Malo JL, Gautrin D. Irritant-induced asthma and reactive airway dysfunction syndrome. In: Malo JL, Chan-Yeung M and Bernstein DI, editors. Asthma in the workplace. Fourth Edition. Boca Raton; CRC Press; 2013, pp 305-24.
26. Baur X, Sigsgaard T, Aasen TB, Burge PS, Heederik D, Henneberger P, Maestrelli P, Rooyackers J, Schlunssen V, Vandenplas O, Wilken D; ERS Task Force on the Management of Work-related Asthma. Guidelines for the management of work-related asthma. Eur Respir J. 2012; 39: 529-45.
27. Malo JL, Vandenplas O. Definitions and classification of workrelated asthma. Immunol Allergy Clin N Am. 2011; 31: 645-62.
28. Malo JL, Ghezzo H, L'Archeveque J, Lagier F, Perrin B, Cartier A. Is the clinical history a satisfactory mean of diagnosing occupational asthma? Am Rev Respir Dis. 1991; 143: 528-2.
29. Vandenplas O, Ghezzo H, Munoz X, Moscato G, Perfetti L, Lemiere C, Labrecque M, L'Archeveque J, Malo JL. What are the questionnaire items most useful in identifying subjects with occupational asthma? Eur Respir J. 2005; 26: 1056-63.
30. Baur X. A compendium of causative agents of occupational asthma. J Occup Med Toxicol. 2013; 8: 15.
31. Cartier A, Sastre J. Clinical assessment of occupational asthma and its differential diagnosis. Immunol Allergy Clin North Am. 2011; 31: 717-28.
32. Castillo C, Lara B, Cruz MJ, Munoz X. Protein identification of two allergens of Boletus edulis causing occupational asthma. Am J Respir Crit Care Med. 2013; 187: 1146-8.
33. Gomez-Olles S, Untoria MD, Villalbi JR, Munoz X, Morell F, Cruz MJ. Soy aeroallergens in thoracic fraction particles (PM10). J Investig Allergol Clin Immunol. 2013; 23: 152-8.
34. Mapp CE, Boschetto P, Maestrelli P, Fabbri LM. Occupational asthma. Am J Respir Crit Care Med. 2005; 172: 280-305.
35. Chan-Yeung M, Malo JL. Occupational asthma. N Engl J Med 1995; 333: 107-12.
36. Garcia-Rio F, Calle M, Burgos F, Casan P, del Campo F, Galdiz JB, Giner J, Gonzalez-mangado N, Ortega F, Puente-Maestu L. Espirometria. Arch Bronconeumol. 2013; 49: 388-401.
37. Perpina Tordera M, Garcia Rio F, Alvarez Gutierrez FJ, Cisneros Serrano C, Compte Torrero L, Entrenas Costa LM. Normativa sobre el estudio de la hiperrespuesta bronquial inespecifica en el asma. Arch Bronconeumol. 2013; 49: 432-46. http://dx. doi. org/10. 1016/j. arbres. 2013. 05. 001.
38. Cote J, Kennedy S, Chang-Yeung M. Sensitivity and specificity of PC20 and peak expiratory flow rate in red cedar asthma. J Allergy Clin Immunol. 1990; 85: 592-8.
39. Sastre J, Fernandez-Nieto M, Novalbos A, De Las Heras M, Cuesta J, Quirce S. Need for monitoring nonspecific bronchial hyperresponsiveness before and after isocyanate inhalation challenge. Chest. 2003; 123: 1276-9.
40. Malo JL, Cardinal S, Ghezzo H, L'Archeveque J, Castellanos L, Maghni K. Association of bronchial reactivity to occupational agents with methacholine reactivity, sputum cells and immunoglobulin E-mediated reactivity. Clin Exp Allergy. 2011; 41: 497-504.
41. Burge PS, O'Brien I, Harries M. Peak flow rate record in the diagnosis of occupational asthma due to colophony. Thorax. 1979; 34: 308-16.
42. Burge PS, O'Brien I, Harries M. Peak flow rate record in the diagnosis of occupational asthma due to isocyanates. Thorax. 1979; 34: 317-23.
43. Perrin B, Lagier F, L'Archeveque J, Cartier A, Boulet LP, Cote J, Malo JL. Occupational asthma: validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge. Eur Respir J. 1992; 5: 40-8.
44. Gannon PF, Newton DT, Belcher J, Pantin CF, Burge PS. Development of OASYS-2: a system for the analysis of serial measurement of peak expiratory flow in workers with suspected occupational asthma. Thorax. 1996; 51: 484-9.
45. Girard F, Chaboillez S, Cartier A, Cote J, Hargreave FE, Labrecque M, Malo JL, Tarlo SM, Lemiere C. An effective strategy for diagnosing occupational asthma: use of induced sputum. Am J Respir Crit Care Med. 2004; 170: 845-50.
46. Munoz X, Velasco MI, Culebras M, Roca O, Morell F, Cruz MJ. Utility of exhaled breath condensate pH for diagnosing occupational asthma. Int Arch Allergy Immunol. 2012; 159: 313-20.
47. Serra Batlles J, Plaza V, Comella A. Cambios en la clinica, la funcion pulmonar, la calidad de vida y los costes en una cohorte de pacientes asmaticos seguidos durante 10 anos. Arch Bronconeumol. 2011; 47: 482-7.
48. Malo JL, Trudeau C, Ghezzo H, L'Archeveque J, Cartier A. Do subjects investigated for occupational asthma through serial peak expiratory flow measurements falsify their results? J Allergy Clin Immunol. 1995; 96: 601-7.
49. Simpson JL, Wood LG, Gibson PG. Inflammatory mediators in exhaled breath, induced sputum and saliva. Clin Exp Allergy. 2005; 35: 1180-5.
50. Wadsworth S, Sin D, Dorscheid D. Clinical update on the use of biomarkers of airway inflammation in the management of asthma. J Asthma Allergy. 2011; 4: 77-86.
51. Prieto L. Induced sputum as a method for the study of bronchial inflammation. Arch Bronconeumol. 2011; 47: 323-4.
52. Raulf-Heimsoth M, Liebig R, Marczynski B, Borowitzki G, Bernard S, Freundt S, Heinze E, Bruning T, Merget R. Implementation of non-invasive methods in the diagnosis of diisocyanate-induced asthma. Adv Exp Med Biol. 2013; 788: 293-300.
53. Lemiere C, Pizzichini MM, Balkissoon R, Clelland L, Efthimiadis A, O'Shaughnessy D, Dolovich J, Hargreave FE. Diagnosing occupational asthma: use of induced sputum. Eur Respir J. 1999; 13: 482-8.
54. Leigh R, Hargreave FE. Occupational neutrophilic asthma. Can Respir J. 1999; 6: 194-6.
55. Anees W, Huggins V, Pavord ID, Robertson AS, Burge PS. Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants. Thorax. 2002; 57: 231-6.
56. Vandenplas O, D'Alpaos V, Heymans J, Jamart J, Thimpont J, Huaux F, Lison D, Renauld JC. Sputum eosinophilia: an early marker of bronchial response to occupational agents. Allergy. 2009; 64: 754-61.
57. Lemiere C, Chaboillez S, Welman M, Maghni K. Outcome of occupational asthma after removal from exposure: A followup study. Can Respir J. 2010; 17: 61-6.
58. Perez de Llano LA. Nitric oxide (NO) in managing asthma. Arch Bronconeumol. 2012; 48: 35-6.
59. Quirce S, Lemiere C, de Blay F, del Pozo V, Gerth Van Wijk R, Maestrelli P, Pauli G, Pignatti P, Raulf-Heimsoth M, Sastre J, Storaas T, Moscato G. Noninvasive methods for assessment of airway inflammation in occupational settings. Allergy. 2010; 65: 445-58.
60. Lemiere C. Non-invasive assessment of airway inflammation in occupational lung diseases. Curr Opin Allergy Clin Immunol. 2002; 2: 109-14.
61. Lemiere C, Cartier A, Malo JL, Lehrer SB. Persistent specific bronchial reactivity to occupational agents in workers with normal nonspecific bronchial reactivity. Am J Respir Crit Care Med. 2000; 162(3 Pt 1): 976-80.
62. Banks DE. Use of the specific challenge in the diagnosis of occupational asthma: a 'gold standard' test or a test not used in current practice of occupational asthma? Curr Opin Allergy Clin Immunol. 2003; 3: 101-7.
63. Cruz MJ, Munoz X. The current diagnostic role of the specific occupational laboratory challenge test. Curr Opin Allergy Clin Immunol. 2012; 12: 119-25.
64. Rioux JP, Malo JL, L'Archeveque J, Rabhi K, Labrecque M. Workplace-specific challenges as a contribution to the diagnosis of occupational asthma. Eur Respir J. 2008; 32: 997-1003.
65. Ewald-Kleimeier S, Lotz A, Merget R, Bruning T, Hagemeyer O. Exhaled nitric oxide in specific inhalation challenge. Adv Exp Med Biol. 2013; 788: 255-64.
66. Sastre J, Costa C, Garcia del Potro M, Aguado E, Mahillo I, Fernandez-Nieto M. Changes in exhaled nitric oxide after inhalation challenge with occupational agents. J Invest Allergol Clin Immunol. 2013; 23(6): 421-7.
67. Santos MS, Jung H, Peyrovi J, Lou W, Liss GM, Tarlo SM. Occupational asthma and work-exacerbated asthma: factors associated with time to diagnostic steps. Chest. 2007; 131: 1768-75.
68. Campo P, Lummus ZL, Bernstein DI. Advances in methods used in evaluation of occupational asthma. Curr Opin Pulm Med. 2004; 10: 142-6.
69. Goldoni M, Catalani S, De Palma G, Manini P, Acampa O, Corradi M, Bergonzi R, Apostoli P, Mutti A. Exhaled breath condensate as a suitable matrix to assess lung dose and effects in workers exposed to cobalt and tungsten. Environ Health Perspect. 2004; 112: 1293-8.
70. Corradi M, Sanchez Mdel M, Acampa O, Caglieri A, Goldoni M, Andreoli R, Manini P, Mutti A. Non-invasive assessment of lung pathobiology in hairdressers. Med Lav. 2008; 99: 49-57.
71. Ferrazzoni S, Scarpa MC, Guarnieri G, Corradi M, Mutti A, Maestrelli P. Exhaled nitric oxide and breath condensate ph in asthmatic reactions induced by isocyanates. Chest. 2009; 136: 155-62.
72. Klusackova P, Lebedova J, Kacer P, Kuzma M, Brabec M, Pelclova D, Fenclova Z, Navratil T. Leukotrienes and 8-isoprostane in exhaled breath condensate in bronchoprovocation tests with occupational allergens. Prostaglandins Leukot Essent Fatty Acids. 2008; 78: 281-92.
73. Beach J, Russell K, Blitz S, Hooton N, Spooner C, Lemiere C, Tarlo SM, Rowe BH. A systematic review of the diagnosis of occupational asthma. Chest. 2007; 131: 569-578.
74. Wiszniewska M, Nowakowska-Świrta E, Pałczyński C, Walusiak-Skorupa J. Diagnosing of bakers' respiratory allergy: is specific inhalation challenge test essential? Allergy Asthma Proc. 2011; 32: 111-8.
75. Cockcroft DW, Murdock KY, Kirby J, Hargreave FE. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine. Am Rev Respir Dis. 1987; 135: 264-7.
76. Vandenplas O, D'Alpaos V, Evrard G, Jamart J. Incidence of severe asthmatic reactions after challenge exposure to occupational agents. Chest. 2013; 143: 1261-8.
77. Munoz X, Cruz MJ, Orriols R, Torres F, Espuga M, Morell F. Validation of specific inhalation challenge for the diagnosis of occupational asthma due to persulphate salts. Occup Environ Med. 2004; 61: 861-6.
78. Andujar R, Cruz MJ, Villar A, Morell F, Munoz X. High eosinophil levels and poor clinical course in occupational asthma due to cyanoacrylate exposure. Am J Ind Med. 2011; 54: 714-8.
79. Vandenplas O, Malo JL, Cartier A, Perreault G, Cloutier Y. Closed-circuit methodology for inhalation challenge test with isocyanates. Am Rev Respir Dis. 1992; 145: 582-7.
80. Caron S, Boileau JC, Malo JL, Leblond S. New methodology for specific inhalation challenge with occupational agents. Respir Res. 2010; 141: 72.
81. D'Alpaos V, Vandenplas O, Evrard G, Jamart J. Inhalation challenges with occupational agents: threshold duration of exposure. Repir Med. 2013; 107: 739-44.
82. Lemiere c, Boulet LP, Chaboillez S, Forget A, Chiry S, Villeneuve H, Prince P, Maghni K, Kennedy WA, Blais L. Work-exacerbated asthma and occupational asthma: do they really differ? J Allergy Clin Immunol. 2013; 131: 704-10.
83. Chiry S, Cartier A, Malo JL, Tarlo SM, Lemiere C. Comparison of peak expiratory flow variability between workers with work-exacerbated asthma and occupational asthma. Chest. 2007; 132: 483-8.
84. Sanchez-Vidaurre S, Cruz MJ, Gomez-Olles S, Morell F, Munoz X. Diagnostic utility of exhaled breath condensate analysis in conjunction with specific inhalation challenge in individuals with suspected work-related asthma. Ann Allergy Asthma Immunol. 2012; 108: 151-6.
85. Caldeira RD, Bettiol H, Barbieri MA, Terra-Filho J, Garcia CA, Vianna EO. Prevalence and risk factors for work-related asthma in young adults. Occup Environ Med. 2006; 63: 694-9.
86. Blanc PD, Ellbjar S, Janson C, Norback D, Norrman E, Plaschke P, Toren K. Asthma-related work disability in Sweden. The impact of workplace exposures. Am J Respir Crit Care Med. 1999; 160: 2028-33.
87. Henneberger PK, Wagner GR, Lemiere C. Asthma exacerbated at work. In: Malo JL, Chan-Yeung M and Bernstein DI, editors. Asthma in the workplace. Fourth Edition. Boca Raton; CRC Press; 2013, p. 325-35.
88. Carazo Fernandez L, Fernandez Alvarez R, Gonzalez-Barcala FJ, Rodriguez Portal JA. Contaminacion del aire interior y su impacto en la patologia respiratoria. Arch Bronconeumol 2013; 49: 22-7.
89. Roger A, Vazquez R, Almonacid C, Padilla A, Serrano J, Garcia-Salmones M, Molina F, Pinedo C, Torrejon M, Picado C, Lopez-Vina A, Plaza V; Grupo Emergente Asma. Area Asma de SEPAR. Knowledge of their own allergic sensitizations in asthmatic patients and its impact on the level of asthma control. Arch Bronconeumol. 2013; 49: 289-96.
90. Perez Pimiento A, Bueso-Fernandez A, Garcia-Loria J, Rodriguez-Cabreros MI, Mosquera MR, Garcia-Cubero A. Effect of omalizumab treatment in a baker with occupational asthma. J Invest Allergol Clin Immunol. 2008; 18(6): 482-95.
91. Lavaud F, Bonniaud P, Dalphin JC, Leroyer C, Muller D, Tannous R, Mangiapan G, De Baly F. Usefulness of omalizumab in ten patients with severe occupational asthma. Allergy. 2013; 68: 813-5.
92. Martinez-Moratalla J, Almar E, Anto JM. Changes in asthma treatment in the Spanish cohort of the European Community Respiratory Health Survey (ECRHS) from 1991-2001: A perspective over time. Arch Bronconeumol. 2013; 49: 113-8.
93. Munoz X, Gomez-Olles S, Cruz MJ, Untoria MD, Orriols R, Morell F. Course of bronchial hyperresponsiveness in patients with occupational asthma caused by exposure to persulphate salts. Arch Bronconeumol. 2008; 44: 140-5.
94. Rosenberg N, Garnier R, Rousselin X, Mertz R, Gervais P. Clinical and socioprofessional fate of isocyanate-induced asthma. Clin Allergy. 1987; 17: 55-61.
95. Perfetti L, Cartier A, Gezzo H, Gautrin D, Malo JL. Follow-up of occupational asthma after removal from or diminution of exposure to the responsible agent: Relevance of the length of the interval from cessation of exposure. Chest. 1998; 114: 398-403.
96. Vandenplas O, Tore K, Blanch PD. Health and socioeconomic impact of work-related asthma. Eur Respir J. 2003; 22: 689-97.
97. Birdi K, Beach J. Management of sensitizer-induced occupational asthma: avoidance or reduction of exposure? Curr Opin Allergy Clin Immunol. 2013; 13: 132-7.
98. Beach J, Rowe BH, Blitz S, Crumley E, Hooton N, Russell K, Spooner C, Klassen T. Evidence Report/Technology Assessment No 129. (Prepared by the University of Alberta Evidencebased Practice Center, under Contract No 290-02-0023). AHRQ Publication No 06-E003-2. Rockville, MD: Agency for Healthcare Research and Quality. November 2005. (Available at: www. ahrq. gov).
99. Rachiotis G, Savani R, Brant A, MacNeill SJ, Newman Taylor A, Cullinan P. The outcome of occupational asthma after cessation of exposure: a systematic review. Thorax. 2007; 62: 147-52.
100. Vandenplas O, Dressel H, Wilken D, Jamart J, Heederik D, Maestrelli P, Sigsgaard T, Henneberger P, Baur X, on behalf of the ERS Task Force on the Management of Work-related Asthma. Management of occupational asthma: cessation or reduction of exposure? A systematic review of available evidence. Eur Respir J. 2011; 38: 804-11.
101. de Groene GJ, Pal TM, Beach J, Tarlo SM, Spreeuwers D, Frings-Dresen MH, Mattioli S, Verbeek JH. Workplace interventions for treatment of occupational asthma. Cochrane Database Syst Rev. 2011; (5): CD006308.
102. Vandenplas O, Dressel H, Nowak D, Jamart J on behalf of ERS Task Force on the Management of Work-related Asthma. What is the optimal management option for occupational asthma? Eur Respir Rev. 2012; 21: 97-104.
103. Maestrelli P, Schlunssen V, Mason P, Sigsgaard T; ERS Task Force on the Management of Work-related Asthma. Task Force on the Management of Work-related Asthma. Contribution of host factors and workplace exposure to the outcome of occupational asthma. Eur Respir Rev. 2012; 21: 88-96.
104. Talini D, Novelli F, Bacci E, Costa F, Dente FL, Di Franco A, Malagrino L, Vagaggini B, Paggiaro P. Mild improvement in symptoms and pulmonary function in a long-term follow-up of patients with toluene diisocyanate-induced asthma. Int Arch Allergy Immunol. 2013; 161: 189-94.
105. Baur X, Sigsgaard T, Aasen TB, Burge PS, Heederik D, Henneberger P, Maestrelli P, Rooyackers J, Schunssen V, Vandenplas O, Wilken D on behalf of the ERS task Force on the Management of Work-Related-Asthma. Guidelines for the management of work-related asthma. Eur Respir J. 2012; 39: 529-45.